 | Apellis Pharmaceuticals, Inc. | |||
| NasdaqGS : APLS || Location: United States | ||||
$64.73+2.4 (+3.85%) |
0.67 M | 61.28 - 65.5 | ||
| Last Updated:08/09/2022 15:05 | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| July 15, 2022 | 9.367 M |
| June 30, 2022 | 9.798 M |
| June 15, 2022 | 9.147 M |
| May 31, 2022 | 8.968 M |
| May 13, 2022 | 9.150 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 03/31/2022 | -1.32 | -1.42 | -7.60% |
| 12/31/2021 | -1.54 | -1.61 | -4.50% |
| 09/30/2021 | -1.70 | -2.28 | -34.10% |
| 06/30/2021 | -1.69 | -2.72 | -60.90% |
| 03/31/2021 | -1.62 | -2.32 | -43.20% |
APLS Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 106.522M | Shares Float | 80.701M |
| Short Float | 9.367M | Market Cap | 6746.04M |
| Institution ownership | 90.92% | Insider ownership | 15.672% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | -7.87 | Forward EPS | -4.40 |
Peers
| Symbol | Price | Change $ | Day Range | Volume |
|---|---|---|---|---|
| ABBV | 140.3516 | +0.01 | 139.875 - 142.18 | 2.39M |
| AMGN | 248.52 | +1.23 | 247.235 - 249.55 | 1.25M |
| GILD | 61.773 | +0.17 | 61.38 - 61.98 | 3.03M |
| VRTX | 298.5975 | +4.65 | 293.95 - 301.73 | 1.0M |
| REGN | 623.4419 | -7.19 | 617.31 - 634.41 | 0.27M |
| BIIB | 216.78 | -0.78 | 214.33 - 218.6 | 0.34M |
| SGEN | 176.08 | -2.25 | 175.1 - 178.38 | 0.41M |
| MRNA | 170.34 | -12.6 | 169.2021 - 180.71 | 3.84M |